• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾上腺素自动注射器:个体化设备和剂量,以优化社区环境中的过敏反应管理。

Epinephrine autoinjectors: individualizing device and dosage to optimize anaphylaxis management in the community setting.

机构信息

From the Division of Clinical Immunology and Allergy, Department of Medicine, Western University, London, Ontario, Canada.

Division of Allergy and Clinical Immunology, McGill University, Montreal, Quebec, Canada.

出版信息

Allergy Asthma Proc. 2023 Jan 1;44(1):45-50. doi: 10.2500/aap.2023.44.220073.

DOI:10.2500/aap.2023.44.220073
PMID:36719691
Abstract

Anaphylaxis is the most severe manifestation of a systemic allergic reaction, and, in the community setting, the immediate administration of an epinephrine autoinjector (EAI) can be life-saving. Physicians are tasked with selecting the most appropriate EAI for each individual and counseling patients and/or their caregivers to maximize the likelihood of successful deployment of the EAI. To offer an evidence-based expert clinical perspective on how physicians might best tailor EAI selection to their patients with anaphylaxis. A group of eight adult and pediatric allergists with expertise in anaphylaxis management reviewed and assessed the published data and guidelines on anaphylaxis management and EAI device selection. Personalized EAI selection is influenced by intrinsic individual factors, extrinsic factors such as the properties of the individual EAI (e.g., dose, needle length, overall design) as well as cost and coverage. The number and the variety of EAIs available have expanded in most jurisdictions in recent years, which provide a greater diversity of options to meet the characteristics and needs of patients with anaphylaxis. There currently are no EAIs with customizable dose and needle length. Although precise personalization of each patient's EAI remains an optimistic future aspiration, careful consideration of all variables when prescribing EAIs can support optimal management of anaphylaxis.

摘要

过敏反应是全身性过敏反应最严重的表现,在社区环境中,立即使用肾上腺素自动注射器(EAI)可挽救生命。医生的任务是为每个个体选择最合适的 EAI,并对患者和/或其照顾者进行咨询,以最大程度地提高 EAI 成功使用的可能性。为了提供基于证据的专家临床观点,说明医生如何根据过敏反应患者的具体情况选择 EAI。一组具有过敏反应管理专业知识的 8 位成人和儿科过敏症专家审查并评估了过敏反应管理和 EAI 设备选择的已发表数据和指南。个性化 EAI 的选择受到内在个体因素、个体 EAI 的外在因素(例如剂量、针头长度、整体设计)以及成本和覆盖范围的影响。近年来,大多数司法管辖区的 EAI 数量和种类都有所增加,这为满足过敏反应患者的特征和需求提供了更多的选择。目前还没有可定制剂量和针头长度的 EAI。尽管为每个患者的 EAI 进行精确的个性化设置仍然是一个乐观的未来愿望,但在开处方 EAI 时仔细考虑所有变量可以支持过敏反应的最佳管理。

相似文献

1
Epinephrine autoinjectors: individualizing device and dosage to optimize anaphylaxis management in the community setting.肾上腺素自动注射器:个体化设备和剂量,以优化社区环境中的过敏反应管理。
Allergy Asthma Proc. 2023 Jan 1;44(1):45-50. doi: 10.2500/aap.2023.44.220073.
2
A Cost-Effectiveness Analysis of Epinephrine Autoinjector Risk Stratification for Patients with Food Allergy-One Epinephrine Autoinjector or Two?一文读懂食物过敏患者肾上腺素自动注射器的风险分层:一支好,还是两支好?
J Allergy Clin Immunol Pract. 2021 Jun;9(6):2440-2451.e3. doi: 10.1016/j.jaip.2021.01.007. Epub 2021 Jan 21.
3
Epinephrine autoinjector prescription patterns for severe anaphylactic patients in Japan: A retrospective analysis of health insurance claims data.日本严重过敏反应患者肾上腺素自动注射器处方模式:医保索赔数据分析的回顾性研究。
Allergol Int. 2020 Jul;69(3):424-428. doi: 10.1016/j.alit.2020.02.008. Epub 2020 Apr 3.
4
Value of a Second Dose of Epinephrine During Anaphylaxis: A Patient/Caregiver Survey.在过敏反应中第二剂肾上腺素的价值:一项患者/照护者调查。
J Allergy Clin Immunol Pract. 2018 Sep-Oct;6(5):1559-1567. doi: 10.1016/j.jaip.2018.01.019. Epub 2018 Feb 3.
5
Epinephrine autoinjector prescribing following anaphylaxis presentation to the emergency department.肾上腺素自动注射器在急诊科出现过敏反应后的处方。
Allergy Asthma Proc. 2023 Jul 1;44(4):283-290. doi: 10.2500/aap.2023.44.230023.
6
Human factors engineering validation study for a novel 0.1-mg epinephrine auto-injector.新型0.1毫克肾上腺素自动注射器的人因工程学验证研究
Allergy Asthma Proc. 2018 Nov 1;39(6):461-465. doi: 10.2500/aap.2018.39.4171. Epub 2018 Aug 29.
7
Epinephrine, auto-injectors, and anaphylaxis: Challenges of dose, depth, and device.肾上腺素、自动注射器和过敏反应:剂量、深度和装置的挑战。
Ann Allergy Asthma Immunol. 2018 Jul;121(1):53-60. doi: 10.1016/j.anai.2018.05.001. Epub 2018 May 7.
8
Anaphylaxis and epinephrine autoinjector use in pediatric patients with cutaneous mastocytosis.皮肤肥大细胞增多症患儿的过敏反应和肾上腺素自动注射器使用。
Pediatr Dermatol. 2021 Sep;38(5):1080-1085. doi: 10.1111/pde.14800. Epub 2021 Sep 24.
9
Trends and determinants of epinephrine prescriptions: a proxy of anaphylaxis epidemiology?肾上腺素处方的趋势和决定因素:过敏反应流行病学的替代指标?
Curr Opin Allergy Clin Immunol. 2022 Dec 1;22(6):441-449. doi: 10.1097/ACI.0000000000000861. Epub 2022 Sep 27.
10
Patient Carrying Time, Confidence, and Training with Epinephrine Autoinjectors: The RACE Survey.患者使用肾上腺素自动注射器的携带时间、信心和培训:RACE 调查。
J Allergy Clin Immunol Pract. 2019 Sep-Oct;7(7):2252-2261. doi: 10.1016/j.jaip.2019.03.021. Epub 2019 Mar 25.

引用本文的文献

1
Allergy and immunology: At the crossroad of inflammation and disease.过敏与免疫学:炎症与疾病的交叉点。
Allergy Asthma Proc. 2023 Jan 1;44(1):1-2. doi: 10.2500/aap.2023.44.220094.